Bishop J C, Dunstan F D, Nix B J, Reynolds T M, Swift A
School of Mathematics, University of Wales, Cardiff, United Kingdom.
Am J Hum Genet. 1993 Feb;52(2):425-30.
The statistical procedure for discriminating between a Down syndrome or neural tube defect (NTD) fetus and a normal fetus relies, to a great extent, on the reporting of maternal serum alpha-fetoprotein (MSAFP), hCG, and uE3 results in the form of multiples of the median (MoMs). Further, threshold MoMs values for MSAFP, such as 2.5 MoMs, are often used to define a reference range to identify an NTD fetus. We show that a constant threshold-MoMs cutoff for MSAFP values actually refers to different percentiles of MSAFP levels at different gestational ages and that the combining of MoMs values between centers and gestational ages, such as suggested by Wald et al. for deriving a patient-specific risk index, is highly questionable. The results presented in this paper are quite general and will apply to all situations where MoMs are used.
区分唐氏综合征或神经管缺陷(NTD)胎儿与正常胎儿的统计程序在很大程度上依赖于以中位数倍数(MoMs)形式报告的母体血清甲胎蛋白(MSAFP)、人绒毛膜促性腺激素(hCG)和游离雌三醇(uE3)结果。此外,MSAFP的阈值MoMs值,如2.5 MoMs,常被用于定义一个参考范围以识别NTD胎儿。我们表明,MSAFP值的恒定阈值MoMs临界值实际上指的是不同孕周时MSAFP水平的不同百分位数,并且像Wald等人所建议的那样在不同中心和孕周之间合并MoMs值以得出患者特异性风险指数,这是非常值得怀疑的。本文给出的结果非常普遍,将适用于所有使用MoMs的情况。